• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

CLIA - Clinical Laboratory Improvement Amendments

  • Print
  • Share
  • E-mail
-
1 to 5 of 5 Results
Document Number K170293
Results per Page

New Searchexport reports to excelExport to Excel | HelpHelp
Document Parent Analyte Analyte Specialty Complexity Effective Date
Siemens Healthcare Diagnostics Inc., Atellica DT 250 Analyzer  {Siemens Healthcare Diagnostics Inc., Syva Emit II Plus Cocaine Metabolite Assay} 
CR250299 K170293 Cocaine metabolites Toxicology / TDM MODERATE 06/04/2025
Beckman Coulter, Inc., DxC 500i Clinical Analyzer  {Siemens Healthcare Diagnostics, Inc., Syva Emit II Plus Cocaine Metabolite Assay} 
CR250127 K170293 Cocaine metabolites Toxicology / TDM MODERATE 04/14/2025
Beckman Coulter, Inc., DxC 500 AU Clinical Chemistry Analyzer  {Siemens Syva Emit® II Plus Cocaine Metabolite Assay} 
CR230612 K170293 Cocaine metabolites Toxicology / TDM MODERATE 10/30/2023
Beckman Coulter DxC 700 AU Clinical Chemistry Analyzer  
CR170047 K170293 Cocaine metabolites Toxicology / TDM MODERATE 01/24/2018
Beckman Coulter DxC 700 AU Clinical Chemistry Analyzer  {Siemens Healthcare Diagnostics Inc. Emit II Plus Cocaine Metabolite Assay} 
CR170047 K170293 Cocaine metabolites Toxicology / TDM MODERATE 01/24/2018

-
-